NHLBI Structural Heart and Valve Network Prospective Registry

Status: Withdrawn
Location: See location...
Study Type: Observational
SUMMARY

Background: Treatments for structural heart and valve disease are quickly changing. But treatment could be improved. Researchers want to gather data from people with this disease. They want to find problems and seek new ways to make treatments better.

Objective: To find people with structural heart and valve disease with common features to study. To find flaws and patterns in procedures related to this disease. To share findings with other researchers.

Eligibility: People ages 18 and older who are receiving care from the structural heart and valve program at the participating NHLBI structural heart disease network sites that are part of the study

Design: Participants will be screened with their consent. This will occur when they give their standard consent for medical care. Participants will have their data collected in the course of standard medical care. Data include: Demographic data Protected health data Personally identifiable data Medical records Medical images. These could include X-rays, CT scans, and MRI scans. The study could find something that would impact participants care. If this is the case, their doctors will be told. Participants data may be shared with other researchers. ...

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:

• Adults age greater than or equal to 18 years.

• Receiving care from the structural heart and valve program at the participating NHLBI structural heart disease network site.

• Consent to participate in the protocol, directly, or through legally authorized representatives (LAR).

Locations
United States
Georgia
Emory University
Atlanta
Time Frame
Start Date: 2023-01-10
Completion Date: 2023-01-10
Treatments
Cohort 1
All patients undergoing consultation for structural and valve interventional procedures are invited to participate in this registry protocol.
Sponsors
Leads: National Heart, Lung, and Blood Institute (NHLBI)

This content was sourced from clinicaltrials.gov